$11.22
-0.25-2.18%
Last update: Nov 10, 4:00 PM
Enanta Pharmaceuticals Inc
ENTANASDAQ
Enanta Pharmaceuticals fell 2.5% from $11.51 to $11.22, behind the S&P 500's +10.0%. Its worst day was Mar 5 (−10.8%), and its low came Nov 5 at $10.08.
Nov 10, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.87 beat the $-1.06 estimate on $15.1M revenue (est. $15.8M).
−3.6% · S&P 500 −0.8%
Enanta Pharmaceuticals closed at its highest level of the year, 46.4% above where the year started.
Story events cover the past 12 months · Times ET
+1.5% · S&P 500 0.0%
EPS of $-0.42 beat the $-0.74 estimate on $18.6M revenue (est. $15.4M).
+2.2% · S&P 500 −0.3%
Enanta Pharmaceuticals shares rose 9.3%, while the S&P 500 rose 0.7%.
+9.3%, the year's best day · S&P 500 +0.7%
Enanta Pharmaceuticals shares fell 10.8%, while the S&P 500 fell 0.6%.
−10.8%, the year's worst day · S&P 500 −0.6%
EPS of $-0.45 beat the $-0.48 estimate on $17.2M revenue (est. $17.2M).
−6.0% · S&P 500 −0.2%
EPS of $-0.67 missed the $-0.48 estimate on $14.4M revenue (est. $17.1M).
−2.1% · S&P 500 −0.3%
Enanta Pharmaceuticals closed at its lowest level of the year, 12.4% below where the year started.
−5.4% · S&P 500 −4.4%
Where it ended: a close of $11.22 on Nov 10, 2026. Up next: Q4 2026 earnings on Nov 24, 2026 (EPS est. $-0.78, revenue est. $15.5M).
Nothing in the past 12 months.
All ENTA dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ENTA and SPY from Benzinga historical bars. Not investment advice.
